Differential TNF-signaling in chronic inflammatory disorders.
about
Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV InfectionAnti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis ModelSleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1.Prenatal arsenic exposure and shifts in the newborn proteome: interindividual differences in tumor necrosis factor (TNF)-responsive signalingThe CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineagesNeuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signalingAre different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelinationSignal transduction pathways of tumor necrosis factor--mediated lung injury induced by ozone in mice.Inhibition of NO(2), PGE(2), TNF-α, and iNOS EXpression by Shorea robusta L.: An Ethnomedicine Used for Anti-Inflammatory and Analgesic Activity.Picolinic acid in patients with chronic hepatitis C infection: a preliminary reportSustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2.Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.Mineralization/anti-mineralization networks in the skin and vascular connective tissuesBiomechanical strain regulates TNFR2 but not TNFR1 in TMJ cellsNF-kappaB in inflammatory bowel disease.A Systems Toxicology-based Approach Reveals Biological Pathways Dysregulated by Prenatal Arsenic Exposure.Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins.Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice.Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions.Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.Potential avenues for immunotherapy of colitis-associated neoplasia.The role of hypoxia in inflammatory disease (review)The flavone eupatilin inhibits eotaxin expression in an NF-κB-dependent and STAT6-independent manner.Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation.Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2.Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells.Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in SeraTNF-α induces vectorial secretion of IL-8 in Caco-2 cells.Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2.TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion.IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in Caco2 cells.Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.Phosphatidic acid as a regulator of matrix metalloproteinase-9 expression via the TNF-alpha signaling pathway.
P2860
Q27487395-102C8824-99BF-4B7C-9AE6-7C299BF71B4DQ28555141-250E7974-BA82-43F3-9800-51F2FA03B991Q30430842-33270576-FA15-4951-A911-041F3B73466DQ33652487-78470DCE-CA5F-4085-85F0-6A6F34659414Q33745206-4D9544E7-E70B-431E-B6EF-4C00E277B3CFQ33998401-61DBC2FB-5528-43B9-9240-6B25BC513265Q34203214-41882BF8-7AAD-4322-BEF8-B59BADD3A26BQ34262443-E025FB9E-B556-43EE-AC3C-618F788DA7E3Q35203230-5B186B37-C5D0-4715-8145-98E5F5AE7BB3Q35206971-C88A6750-4995-4FE0-A12B-49C83A684ECDQ35855209-078A5580-A9AF-44DD-B3B9-4E9C8B57F994Q35979409-E2591AEF-AB68-4DEF-8080-F44E1028FD92Q36012223-1E4B34F9-538E-4311-BE63-1C628EC01BFFQ36606486-4CD623CD-FE2F-4674-BD8B-E9B6395B9C25Q36633243-E2F178C3-864D-4C8E-B2B6-7DC4E5F0434DQ36863995-0FAB8DD1-92F0-4D98-9379-59C709C69367Q36986492-D5E6038E-9A7A-4DA6-B999-7BC1783B4128Q37104074-A7872F3A-BE50-4156-87D5-E98EE72B0F36Q37163422-65219B44-CC73-478A-9A3F-62A2B8893536Q37186748-309A3A24-1087-42FB-B778-5CD70E3EBFFDQ37228378-C5F2552E-93A4-42B9-9524-E53A5F2E24F9Q37416379-8DE5490C-76F1-4774-A6F6-18CBB8D5EA67Q37424039-E2C16C07-0F61-49FE-B6DA-F307A92EEC00Q37679511-167BEE9A-C589-4581-817B-B10D4CD6D675Q37831189-231C44C8-393E-4B8A-9C9D-9F6C0C307E8FQ38003476-A6384872-6915-4079-B893-6B0A65FEEA8CQ38334119-B8E6AC14-B4DA-476D-92F6-A7BC483B61D2Q38922502-5EF473A2-FAE5-49C0-A21D-C40B50686958Q38974348-76D13E13-9152-4754-9794-3E51E37EEB19Q39696203-61ED2E11-C570-4350-8341-2BC5F6CB584EQ39988374-5D2C6BB2-A507-4AE8-BA52-743C8A453525Q41022804-D5FA23F9-38C9-4323-A017-4BBF7AB5B89DQ41491090-78AC2434-52DD-4596-8735-1AF0E624C5BEQ41771263-379D95CC-DC36-4C96-AF2B-52013A99FE71Q43198420-2ED47649-A772-48B4-9861-6A38DC19DE3EQ46685848-0129B7AE-1418-4448-B24F-F9555C23462BQ47120758-DC0EDB98-834D-4B45-A012-B39512A914FEQ51093833-958FD290-B56D-4518-BBC9-8376A829232BQ52565806-A178AA32-9530-4158-852E-FC387CE73327Q53579172-CC4C044B-CD80-4BF2-982F-A08384CC0E28
P2860
Differential TNF-signaling in chronic inflammatory disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Differential TNF-signaling in chronic inflammatory disorders.
@ast
Differential TNF-signaling in chronic inflammatory disorders.
@en
type
label
Differential TNF-signaling in chronic inflammatory disorders.
@ast
Differential TNF-signaling in chronic inflammatory disorders.
@en
prefLabel
Differential TNF-signaling in chronic inflammatory disorders.
@ast
Differential TNF-signaling in chronic inflammatory disorders.
@en
P356
P1476
Differential TNF-signaling in chronic inflammatory disorders.
@en
P2093
Markus F Neurath
Martin H Holtmann
P304
P356
10.2174/1566524043360636
P577
2004-06-01T00:00:00Z